Cargando…

Stability of 3-bromotyrosine in serum and serum 3-bromotyrosine concentrations in dogs with gastrointestinal diseases

BACKGROUND: 3-Bromotyrosine (3-BrY) is a stable product of eosinophil peroxidase and may serve as a marker of eosinophil activation. A gas chromatography/mass spectrometry method to measure 3-BrY concentrations in serum from dogs has recently been established and analytically validated. The aims of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sattasathuchana, Panpicha, Grützner, Niels, Lopes, Rosana, Guard, Blake C, Suchodolski, Jan S, Steiner, Jörg M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299803/ https://www.ncbi.nlm.nih.gov/pubmed/25595676 http://dx.doi.org/10.1186/s12917-015-0321-0

Ejemplares similares

Serum and Fecal 3-Bromotyrosine Concentrations in Dogs with Chronic Inflammatory Enteropathy: Clinical Parameters and Histopathological Changes
por: Sattasathuchana, Panpicha, et al.
Publicado: (2023)

Evaluation of Serum 3‐Bromotyrosine Concentrations in Dogs with Steroid‐Responsive Diarrhea and Food‐Responsive Diarrhea
por: Sattasathuchana, P., et al.
Publicado: (2017)

The metabolism and de-bromination of bromotyrosine in vivo
por: Mani, Ali R., et al.
Publicado: (2016)

Antiparasitic Bromotyrosine Derivatives from the Marine Sponge Verongula rigida
por: Galeano, Elkin, et al.
Publicado: (2011)

Bromotyrosine-derived alkaloids from the Caribbean sponge Aplysina lacunosa
por: Göthel, Qun, et al.
Publicado: (2015)

Synthesis and Cytotoxicity Evaluation of Spirocyclic Bromotyrosine Clavatadine C Analogs
por: Patel, Piyush A., et al.
Publicado: (2021)

Bioactive Bromotyrosine-Derived Alkaloids from the Polynesian Sponge Suberea ianthelliformis
por: El-Demerdash, Amr, et al.
Publicado: (2018)

Synthesis and Antiproliferative Activity of Marine Bromotyrosine Purpurealidin I and Its Derivatives
por: Bhat, Chinmay, et al.
Publicado: (2018)

Marine biomimetics: bromotyrosines loaded chitinous skeleton as source of antibacterial agents
por: Muzychka, Liubov, et al.
Publicado: (2021)

Presence of Bromotyrosine Alkaloids in Marine Sponges Is Independent of Metabolomic and Microbiome Architectures
por: Mohanty, Ipsita, et al.
Publicado: (2021)

A short and efficient total synthesis of the bromotyrosine-derived alkaloid psammaplysene A
por: Xu, Jingjing, et al.
Publicado: (2018)

Cytotoxic Anomoian B and Aplyzanzine B, New Bromotyrosine Alkaloids from Indonesian Sponges
por: Tarazona, Guillermo, et al.
Publicado: (2017)

Synthesis of the Marine Bromotyrosine Psammaplin F and Crystal Structure of a Psammaplin A Analogue
por: Yang, Qianjiao, et al.
Publicado: (2010)

Bromotyrosine-Derived Metabolites from a Marine Sponge Inhibit Pseudomonas aeruginosa Biofilms
por: Tran, Tam M. T., et al.
Publicado: (2023)

New Antimicrobial Bromotyrosine Analogues from the Sponge Pseudoceratina purpurea and Its Predator Tylodina corticalis
por: Gotsbacher, Michael P., et al.
Publicado: (2015)

Ceratinadins E and F, New Bromotyrosine Alkaloids from an Okinawan Marine Sponge Pseudoceratina sp.
por: Kurimoto, Shin-ichiro, et al.
Publicado: (2018)

Aplysinopsin-type and Bromotyrosine-derived Alkaloids from the South China Sea Sponge Fascaplysinopsis reticulata
por: Wang, Qi, et al.
Publicado: (2019)

Bioactive Bromotyrosine Derivatives from the Pacific Marine Sponge Suberea clavata (Pulitzer-Finali, 1982)
por: Moriou, Céline, et al.
Publicado: (2021)

Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies
por: Heilmann, Romy M., et al.
Publicado: (2017)

Preparation of Biphenyl-Conjugated Bromotyrosine for Inhibition of PD-1/PD-L1 Immune Checkpoint Interactions
por: Kim, Eun-Hye, et al.
Publicado: (2020)

Anti-Tumor Activity vs. Normal Cell Toxicity: Therapeutic Potential of the Bromotyrosines Aerothionin and Homoaerothionin In Vitro
por: Drechsel, Antje, et al.
Publicado: (2020)

Quorum Sensing Inhibitory and Antifouling Activities of New Bromotyrosine Metabolites from the Polynesian Sponge Pseudoceratina n. sp.
por: Tintillier, Florent, et al.
Publicado: (2020)

Fecal short‐chain fatty acid concentrations and dysbiosis in dogs with chronic enteropathy
por: Minamoto, Yasushi, et al.
Publicado: (2019)

Using UHPLC–MS profiling for the discovery of new sponge-derived metabolites and anthelmintic screening of the NatureBank bromotyrosine library
por: Hayes, Sasha, et al.
Publicado: (2022)

High-Dose Hydrocortisone Treatment Does Not Affect Serum C-Reactive Protein (CRP) Concentrations in Healthy Dogs
por: Heilmann, Romy M., et al.
Publicado: (2023)

Association of clinical characteristics and lifestyle factors with fecal S100/calgranulin concentrations in healthy dogs
por: Heilmann, Romy M., et al.
Publicado: (2021)

Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease
por: Blake, Amanda B., et al.
Publicado: (2019)

Serum α(1)-Proteinase Inhibitor, Calprotectin, and S100A12 Concentrations in the Characterization of Pancreatitis in Dogs
por: Jandel, Annina N., et al.
Publicado: (2023)

Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease
por: Lawrence, Yuri A., et al.
Publicado: (2019)

Serum canine pancreatic-specific lipase concentrations in dogs with naturally occurring Babesia rossi infection
por: Köster, Liza S., et al.
Publicado: (2015)

Serum triglyceride and cholesterol concentrations and lipoprotein profiles in dogs with naturally occurring pancreatitis and healthy control dogs
por: Xenoulis, Panagiotis G., et al.
Publicado: (2020)

Analytical Validation of an Assay for Concurrent Measurement of Amino Acids in Dog Serum and Comparison of Amino Acid Concentrations between Whole Blood, Plasma, and Serum from Dogs
por: Blake, Amanda B., et al.
Publicado: (2022)

Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies
por: Heilmann, Romy M., et al.
Publicado: (2018)

Effect of selected gastrointestinal parasites and viral agents on fecal S100A12 concentrations in puppies as a potential comparative model
por: Heilmann, Romy M., et al.
Publicado: (2018)

Molecular prevalence of Dirofilaria immitis and Wolbachia infections in pet and semi-domesticated cats in Bangkok, Thailand
por: Thengchaisri, Naris, et al.
Publicado: (2022)

Characterization of Microbial Dysbiosis and Metabolomic Changes in Dogs with Acute Diarrhea
por: Guard, Blake C., et al.
Publicado: (2015)

Serum cobalamin and methylmalonic acid concentrations in juvenile dogs with parvoviral enteritis or other acute enteropathies
por: Hung, Michael, et al.
Publicado: (2023)

Genomic association and further characterisation of faecal immunoglobulin A deficiency in German Shepherd dogs
por: Grützner, Niels, et al.
Publicado: (2021)

The fecal microbiome and metabolome differs between dogs fed Bones and Raw Food (BARF) diets and dogs fed commercial diets
por: Schmidt, Milena, et al.
Publicado: (2018)

Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma
por: Heilmann, Romy M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a6cr7tp0gkjvn1g86g2pnlnb5i